Filing Details
- Accession Number:
- 0001415889-24-009028
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-25 16:03:33
- Reporting Period:
- 2024-03-22
- Accepted Time:
- 2024-03-25 16:03:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1790340 | Immuneering Corp | IMRX | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1423084 | J. Thomas Schall | C/O Immuneering Corporation 245 Main Street, 2Nd Floor Cambridge MA 02142 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2024-03-22 | 2,900 | $2.55 | 2,900 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- This transaction was executed in multiple trades through a broker-dealer at prices ranging from $2.53 to $2.55. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price.